SH3GL2 and cancer: Furthermore, pan-cancer analysis of the hub genes revealed three genes, namely, CACNA1E, DDN, and SH3GL2, which were predominantly downregulated in GBM but not identified in more than five cancer types, could also make them putative prognostic biomarkers for GBM.